PROS1 and lung carcinoma: In the lung cancer group, AZD1222 induced lower antibody titers against the S protein (54.0; IQR 96.49 vs. 99.04; IQR 14.53; p = 0.004) and lower levels of memory B cells (16.90; IQR 17.7 vs. 29.60; IQR 15.43; p = 0.055) compared with the control group.